pH Sciences

pH Sciences is a private, pre-revenue biotech firm focused on a proprietary drug delivery platform that leverages pH differentials in the body for targeted release. Its technology is designed to enhance the performance of existing and new small molecule therapeutics across various disease areas, potentially improving patient outcomes and safety profiles. As a platform company, it likely seeks partnerships with larger pharmaceutical firms to advance its programs. The company appears to be in a pre-clinical or early development stage, operating with a small team.

Proprietary pH-activated drug delivery systems designed to release small molecule therapeutics in specific physiological environments based on local pH, aiming to enhance efficacy and reduce systemic side effects.

pH Sciences operates in a crowded and competitive field of advanced drug delivery, competing against large-cap pharma internal platforms, public companies like Alkermes, and numerous private biotechs. Differentiation requires demonstrating clear clinical advantages over existing targeted delivery methods (e.g., liposomes, antibody-drug conjugates).